
In line with its geographical expansion plan, Combino Pharm is set to enter the Portuguese market. The company is aiming to position itself as one of the leading laboratories in the hospital generics market providing high-quality products, customer service and competitively priced medicines.
During the course of the year, and by means of its own commercial structure, Combino Pharm Portugal will present an ambitious plan to launch 17 products to Portugal's more than 240 hospitals.
The products that have been available since January this year are Levofloxacino Combino, Ceftazidima Combino and Flumazenilo Combino. Representatives of Combino Pharm Portugal will shortly be in contact with hospitals to arrange a meeting for the company to present these products.







